Clinical Study

Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on Survival

Table 3

Hazard ratios for death compared to complete cytoreduction to no gross residual disease. Hazard Ratios demonstrating the association between the degree of cytoreduction and survival.

Amount of residual diseaseUnivariable hazard ratio95% confidence interval value

All stages≤1 cm1.770.56–5.550.33
>1 cm4.711.84–12.090.001*
Stages II and IV≤1 cm1.500.044–5.130.51
>1 cm3.411.21–9.620.02*

*Statistically significant with < or = 0.05.